首页> 美国卫生研究院文献>Molecules >Selection and Characterization of Single-Stranded DNA Aptamers Binding Human B-Cell Surface Protein CD20 by Cell-SELEX
【2h】

Selection and Characterization of Single-Stranded DNA Aptamers Binding Human B-Cell Surface Protein CD20 by Cell-SELEX

机译:Cell-SELEX筛选结合人B细胞表面蛋白CD20的单链DNA适体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The B-lymphocyte antigen (CD20) is a suitable target for single-stranded (ss) nucleic acid oligomer (aptamers). The aim of study was selection and characterization of a ssDNA aptamer against CD20 using Cell-Systematic Evolution of Ligands by Exponential Enrichment (Cell-SELEX). The cDNA clone of CD20 (pcDNA-CD20) was transfected to human embryonic kidney (HEK293T) cells. Ten rounds of Cell-SELEX was performed on recombinant HEK-CD20 cells. The final eluted ssDNA pool was amplified and ligated in T/A vector for cloning. The plasmids of positive clones were extracted, sequenced and the secondary structures of the aptamers predicted using DNAMAN® software. The sequencing results revealed 10 different types; three of them had the highest thermodynamic stability, named AP-1, AP-2 and AP-3. The AP-1 aptamer was the most thermodynamically stable one (ΔGAP-1 = −10.87 kcal/mol) with the highest binding affinity to CD20 (96.91 ± 4.5 nM). Since, the CD20 is a suitable target for recognition of B-Cell. The selected aptamers could be comparable to antibodies with many advantages. The AP-1, AP-2 and AP-3 could be candidate instead of antibodies for diagnostic and therapeutic applications in immune deficiency, autoimmune diseases, leukemia and lymphoma.
机译:B淋巴细胞抗原(CD20)是单链(ss)核酸寡聚体(适体)的合适靶标。研究的目的是使用通过指数富集的配体细胞系统进化(Cell-SELEX)选择和表征针对CD20的ssDNA适体。将CD20的cDNA克隆(pcDNA-CD20)转染至人胚肾(HEK293T)细胞。在重组HEK-CD20细胞上进行了十轮Cell-SELEX。扩增最终洗脱的ssDNA池,并连接到T / A载体中进行克隆。提取阳性克隆的质粒,进行测序,并使用DNAMAN ®软件预测适体的二级结构。测序结果揭示了10种不同的类型。其中三个具有最高的热力学稳定性,分别为AP-1,AP-2和AP-3。 AP-1适体是最热力学稳定的(ΔGAP-1= -10.87 kcal / mol),对CD20的结合亲和力最高(96.91±4.5 nM)。由于CD20是识别B细胞的合适靶标。所选择的适体可以与具有许多优点的抗体相当。 AP-1,AP-2和AP-3可以替代抗体,用于免疫缺陷,自身免疫性疾病,白血病和淋巴瘤的诊断和治疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号